Evidence map›Paper›PMID 30863083›Full record

ArticleOncoTargets and therapy2019

High-intensity focused ultrasound enhances the effect of bufalin by inducing apoptosis in pancreatic cancer cells.

Zhouyu Ning, Zhenfeng Zhu, Haiyong Wang, Chenyue Zhang, Litao Xu, Liping Zhuang, Xia Yan, Dan Wang, Peng Wang, Zhiqiang Meng

Open access · goldAbstract read
In one paragraph

Article in OncoTargets and therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Focused ultrasound radiosensitizes human cancer cells by enhancement of DNA damage.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2021
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Zhouyu NingDepartment of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China, mengzhq@yeah.net.
Zhenfeng ZhuDepartment of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China, mengzhq@yeah.net.
Haiyong WangDepartment of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China, mengzhq@yeah.net.
Chenyue ZhangDepartment of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China, mengzhq@yeah.net.
Litao XuDepartment of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China, mengzhq@yeah.net.
Liping ZhuangDepartment of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China, mengzhq@yeah.net.
Xia YanDepartment of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China, mengzhq@yeah.net.
Dan WangDepartment of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China, mengzhq@yeah.net.
Peng WangDepartment of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China, mengzhq@yeah.net.
Zhiqiang MengDepartment of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China, mengzhq@yeah.net.
Shanghai Medical College of Fudan University · CNFudan University Shanghai Cancer Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeHigh-intensity focused ultrasound (HIFU) has the potential to be an effective therapeutic strategy for pancreatic cancer (PC). However, owing to the high malignancy and poor prognosis of PC, the use of HIFU therapy alone is not sufficient to impair the progression of PC. Bufalin, a compound extracted from traditional medicine, is known to inhibit the growth and progression of PC cells. However, the effect of the combination therapy of HIFU plus bufalin (HIFU+bufalin) is still uncertain. MATERIALS AND

methodsA colony formation assay and flow cytometry were performed to measure the growth and induction of apoptosis in PC cells. Western blotting was used to explore the potential mechanism of HIFU and bufalin therapy. The in vivo efficacy of HIFU+bufalin was tested in a MiaPaCa

resultsBufalin inhibited the growth of PC cells more obviously compared to HIFU. Combining bufalin with HIFU further decreased the growth of MiaPaCa

conclusionHIFU enhanced the effect of bufailn by inducing apoptosis in PC cells. A combination of HIFU and bufalin may be employed as an alternative therapeutic strategy for PC.

Indexed as

apoptosisbufalinextracorporeal shockwave therapypancreatic neoplasms

Identifiers

PMID30863083
PMCPMC6388946
OpenAlexW2914844445

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.